Stay updated on Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedStudy Morpheus Lung (NCT03337698) was closed early as the sponsor decided not to continue development of certain treatment combinations. The history now reflects termination and updates to results-related sections (Results Posted, Adverse Events, Outcome Measures, Baseline Characteristics, and Study Status).SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays a revised site version (v3.5.3) instead of v3.5.2, indicating a small update to the website's build. This change does not modify the study data or other visible content.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded core results content (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and status/contacts updates to the study record, with a QC note and revision to v3.5.2 dated 2026-04-10.SummaryDifference0.6%

- Check56 days agoChange DetectedAdded a 'Results Submitted' entry and updated the revision to v3.5.0. This replaces the previous 'No Results Posted' status tied to v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision tag v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check99 days agoChange DetectedA new revision (v3.4.2) was added to the history, and two older administrative notices (including a funding lapse notice) were removed.SummaryDifference0.3%

Stay in the know with updates to Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page.